Zacks Research Forecasts Higher Earnings for ProAssurance

ProAssurance Co. (NYSE:PRA) – Research analysts at Zacks Research boosted their Q1 2025 earnings per share estimates for shares of ProAssurance in a research report issued to clients and investors on Wednesday, November 27th. Zacks Research analyst K. Dey now expects that the insurance provider will post earnings per share of $0.17 for the quarter, up from their prior estimate of $0.16. The consensus estimate for ProAssurance’s current full-year earnings is $0.80 per share. Zacks Research also issued estimates for ProAssurance’s Q2 2025 earnings at $0.19 EPS, Q3 2025 earnings at $0.20 EPS, FY2025 earnings at $0.78 EPS, Q1 2026 earnings at $0.18 EPS, Q2 2026 earnings at $0.20 EPS, Q3 2026 earnings at $0.22 EPS and FY2026 earnings at $0.85 EPS.

Several other analysts have also recently commented on PRA. Piper Sandler cut ProAssurance from an “overweight” rating to a “neutral” rating and set a $18.00 price target for the company. in a report on Monday, November 11th. Truist Financial raised their price objective on ProAssurance from $14.00 to $18.00 and gave the company a “hold” rating in a research note on Tuesday, November 12th. Finally, StockNews.com downgraded ProAssurance from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Three research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, ProAssurance currently has a consensus rating of “Hold” and a consensus target price of $18.67.

ProAssurance Stock Down 1.1 %

PRA opened at $16.52 on Monday. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.28 and a quick ratio of 0.28. The business has a 50 day simple moving average of $15.68 and a 200-day simple moving average of $13.88. The stock has a market capitalization of $845.16 million, a P/E ratio of 19.90 and a beta of 0.28. ProAssurance has a 12 month low of $10.76 and a 12 month high of $17.79.

Institutional Investors Weigh In On ProAssurance

A number of hedge funds and other institutional investors have recently made changes to their positions in PRA. Point72 Hong Kong Ltd purchased a new stake in shares of ProAssurance in the second quarter valued at $28,000. nVerses Capital LLC acquired a new position in ProAssurance in the third quarter valued at $44,000. Innealta Capital LLC acquired a new position in ProAssurance in the second quarter valued at $69,000. Point72 Asia Singapore Pte. Ltd. boosted its holdings in ProAssurance by 94.3% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 8,347 shares of the insurance provider’s stock valued at $126,000 after acquiring an additional 4,052 shares during the last quarter. Finally, Susquehanna Fundamental Investments LLC acquired a new position in ProAssurance in the second quarter valued at $166,000. Hedge funds and other institutional investors own 85.58% of the company’s stock.

About ProAssurance

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.